How does MRD guide treatment decisions in ALL?
Elias Jabbour, MD, leukemia professor at the University of Texas MD Anderson Cancer Center, moderates a discussion on acute lymphoblastic leukemia (ALL) MRD-guided
Leukemia News
SOHO 2025
News
Video Interviews
Lymphoma
T-Cell Lymphoma
News
Targeted immune CTCL therapy set for US launch in Q4 2025
Citius Oncology has entered a distribution services agreement with McKesson Corporation for denileukin diftitox-cxdl (LYMPHIR), a novel immunotherapy, for adult patients with relapsed
Leukemia
Acute Lymphoblastic Leukemia
Myeloproliferative Neoplasms
News
Pathways & Perspectives with Gabriela Hobbs, MD
Dr. Hobbs, MPN lead and clinical director for the Adult Leukemia Service at Massachusetts General Hospital, was born in Mexico City, came to
Multiple Myeloma
FDA approves blenrep combo in relapsed or refractory MM
The US Food and Drug Administration (FDA) has approved belantamab mafodotin (blenrep) in combination with bortezomib and dexamethasone (BVd) for the treatment of
Myelodysplastic Syndromes
News
FDA grants orphan drug designation to MDS investigational therapy ofirnoflast
The US Food and Drug Administration (FDA) has granted orphan drug designation to ofirnoflast (HT-6184), an investigational therapy for myelodysplastic symptoms (MDS).
Leukemia
Acute Lymphoblastic Leukemia
Chronic Myeloid Leukemia
News
US launch of tyrosine kinase inhibitor in Ph+ CML, ALL
Cycle Pharmaceuticals launched dasatinib tablets (PHYRAGO). It's a tyrosine kinase inhibitor bioequivalent to Sprycel. The drug treats adults with newly diagnosed or resistant/intolerant
Ambassador Program
Myelodysplastic Syndromes
Society Updates
SOHO MENA returns to in-person meeting for region’s 3rd meeting
Now in its third year, the meeting featured a comprehensive program covering all blood cancers, bringing together world-class clinicians including Drs. Hagop Kantarjian,
SOHO 2025
Educational Resources
Leukemia
Meetings / Conferences
Myelodysplastic Syndromes
News
Improving Outcomes in CHIP/CCUS with Dr. Borate
This Meet the Professor session was delivered by Uma Borate, MD, MS, an associate professor at the Ohio State University Comprehensive Cancer Center,
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Myelodysplastic Syndromes
News
FDA accepts BLA for Orca-T in hematological malignancies
The US Food and Drug Administration (FDA) accepted for priority review the Biologics License Application (BLA) seeking approval for Orca-T (Orca-T), an investigational
Leukemia News
SOHO 2025
Educational Resources
Acute Myeloid Leukemia
Meetings / Conferences
News
Future Role of CPX-351 and CPX-351-Based Combinations
In this Meet the Professor session in acute myeloid leukemia, Jeffrey Lancet, MD, chair of the Department of Malignant Hematology at the Moffitt